In March of 2013, the U.S. Food and Drug Administration (FDA) issued a safety communication linking diabetes drugs known as Incretin Mimetics, which include the brands Januvia, Janumet, Byetta Onglyza Read More
In March of 2013, the U.S. Food and Drug Administration (FDA) issued a safety communication linking diabetes drugs known as Incretin Mimetics, which include the brands Januvia, Janumet, Byetta Onglyza Read More